Grant
Evaluation of Neoadjuvant Carboplatin in Hereditary Triple-negative Breast Cancer in Randomized Settings (ENCHANT study)
Evaluation of Neoadjuvant Carboplatin in Hereditary Triple-negative Breast Cancer in Randomized Settings (ENCHANT study)